Research programs empower our patients to play an active role in their own health care. These kinds of studies are needed to develop new treatments for serious diseases and offer an alternative therapy to the patient. Thousands of people are helped each year because they volunteered to take part in a clinical trial, all while contributing to important medical research for the future benefit of others. Access new, cutting edge treatments, and receive world-class next generation health care – at no cost to you. Our research studies focus on Alzheimer’s disease, Multiple Sclerosis, Migraine, and Parkinson’s disease.
How do Clinical Trials Work?
A clinical trial adheres to a comprehensive plan, or protocol. A protocol is the written description of a clinical trial, which includes the study’s objectives, design and methods as well as relevant scientific background and statistical information.
Comparison groups are used in most clinical trials to compare medical strategies and treatments to see if one group has a better outcome than the other. This is usually conducted in one of two ways:
- One group receives an existing treatment for a condition and the second group receives a new treatment to compare which group has better results
- One group receives a new treatment, and the second group receives a placebo (an inactive product that looks like the test product)
An informed consent document is signed before the trial begins. It outlines your rights, explains what the study involves and contains valuable information for you.
Several appointments take place in a clinical trial – and you must attend all of them. It is a commitment for the volunteer, and we are most grateful.
Your health is constantly monitored and our site offers you 24/7 access to our staff members.
Your privacy is of our utmost concern and we will protect it at all times.
How do I find more Information?
If you are suffering with a neurological disease or disorder, please see our Services page to access the clinical research trials we are currently conducting and for more information on how to get in touch with us.
If you are suffering with a neurological disease or disorder, we encourage you to look into participating in a Clinical Trial. For detailed information about all of our available studies, please click on the links below to view our registry of Clinical Trials:
- An Efficacy and Safety Study of LY3314814 in Early Alzheimer’s Disease Read more +
- Study Evaluating RVT-101 in Subjects With Mild to Moderate Alzheimer’s Disease on Donepezil Treatment: MINDSET Study Read more +
- Study Evaluating RVT-101 in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study Read more +
- SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Read more +
- Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease Read more +
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease Read more +
- Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral AGN-241689 in Episodic Migraine Prevention Read more +
- A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) (the EVOLVE-MS-1 Study) Read more +
- A Study of Ocrelizumab in Patients With Relapsing Remitting Multiple Sclerosis Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment Read more +
- Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis Read more +
- Plegridy Observational Program Read more +
- Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis Read more +
- Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis Read more +
- Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease Read more +